Unichem Laboratories (NSE:UNICHEMLAB) Construction In Progress: ₹1,000 Mil (As of Mar. 2026)


NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
65 GF Score
Price ₹433.00
GF Value ₹686.53
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Unichem Laboratories Construction In Progress?

Unichem Laboratories NSE:UNICHEMLAB -0.13% 65 Construction In Progress is ₹1,000 Mil as of Mar. 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 65/100 and a GF Value™ of ₹686.53 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Unichem Laboratories's quarterly construction in progress declined from Sep. 2025 (₹789 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,000 Mil).

Unichem Laboratories's annual construction in progress declined from Mar. 2024 (₹1,298 Mil) to Mar. 2025 (₹520 Mil) but then increased from Mar. 2025 (₹520 Mil) to Mar. 2026 (₹1,000 Mil).

Unichem Laboratories Construction In Progress Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Construction In Progress Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,938.14 1,541.42 1,297.70 520.20 1,000.14

Unichem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 520.20 0.00 788.80 0.00 1,000.14
NSE:UNICHEMLAB
65GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹1,000 Mil mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a Construction In Progress of ₹1,000 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Unichem Laboratories and its competitors.
Is Unichem Laboratories' Construction In Progress too high?
Unichem Laboratories' current Construction In Progress is ₹1,000 Mil. Overall, Unichem Laboratories has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Construction In Progress compare to ZTS?
Unichem Laboratories' Construction In Progress of ₹1,000 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Unichem Laboratories and its competitors. Unichem Laboratories's current Construction In Progress is ₹1,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹686.53, compared to a current price of ₹433.00 — trading 36.9% below its estimated fair value. The current Construction In Progress is ₹1,000 Mil. Unichem Laboratories' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Construction In Progress is ₹1,000 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹433.00 is trading 36.9% below its estimated GF Value™ of ₹686.53. GuruFocus considers Unichem Laboratories to be Significantly Undervalued.

Key valuation signals for NSE:UNICHEMLAB:

  • Construction In Progress: ₹1,000 Mil
  • GF Value™: ₹686.53 vs. price of ₹433.00 (36.9% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
65GF Score

Get the complete analysis for NSE:UNICHEMLAB

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹433.00
Price
₹686.53
GF Value